Company News for Dec 28, 2023

In this article:
  • Cytokinetics, Incorporated (CYTK) advanced 82.5% as its heart disease drug met late-stage study goals.

  • Tesla (TSLA) shares rose 1.9% following reports from Bloomberg that the company is working on an upgraded version of the Model Y to be manufactured at its Shanghai Gigafactory, scheduled for production commencement in mid-2024.

  • The New York Times Company (NYT) shares gained 2.8% following the company's decision to file a lawsuit against Microsoft Corporation (MSFT) and OpenAI.

  • Shares of Iovance Biotherapeutics, Inc. (IOVA) plunged 18.7% as regulatory authorities imposed a clinical hold on the company's trial of LN-145 for non-small-cell lung cancer.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microsoft Corporation (MSFT) : Free Stock Analysis Report

The New York Times Company (NYT) : Free Stock Analysis Report

Tesla, Inc. (TSLA) : Free Stock Analysis Report

Cytokinetics, Incorporated (CYTK) : Free Stock Analysis Report

Iovance Biotherapeutics, Inc. (IOVA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement